Tateyama M - Search Results

1

A carboxyl-terminal hydrophobic interface is critical to sodium channel function. Relevance to inherited disorders.

Glaaser IW, Bankston JR, Liu H, Tateyama M, Kass RS. Glaaser IW, et al. Among authors: tateyama m. J Biol Chem. 2006 Aug 18;281(33):24015-23. doi: 10.1074/jbc.M605473200. Epub 2006 Jun 22. J Biol Chem. 2006. PMID: 16798729 Free article.

2

Secondary structure of the human cardiac Na+ channel C terminus: evidence for a role of helical structures in modulation of channel inactivation.

Cormier JW, Rivolta I, Tateyama M, Yang AS, Kass RS. Cormier JW, et al. Among authors: tateyama m. J Biol Chem. 2002 Mar 15;277(11):9233-41. doi: 10.1074/jbc.M110204200. Epub 2001 Dec 10. J Biol Chem. 2002. PMID: 11741959 Free article.

3

Channel openings are necessary but not sufficient for use-dependent block of cardiac Na(+) channels by flecainide: evidence from the analysis of disease-linked mutations.

Liu H, Tateyama M, Clancy CE, Abriel H, Kass RS. Liu H, et al. Among authors: tateyama m. J Gen Physiol. 2002 Jul;120(1):39-51. doi: 10.1085/jgp.20028558. J Gen Physiol. 2002. PMID: 12084774 Free PMC article.

4

Modulation of cardiac sodium channel gating by protein kinase A can be altered by disease-linked mutation.

Tateyama M, Rivolta I, Clancy CE, Kass RS. Tateyama M, et al. J Biol Chem. 2003 Nov 21;278(47):46718-26. doi: 10.1074/jbc.M308977200. Epub 2003 Sep 18. J Biol Chem. 2003. PMID: 14500710 Free article.

5

The Na+ channel inactivation gate is a molecular complex: a novel role of the COOH-terminal domain.

Motoike HK, Liu H, Glaaser IW, Yang AS, Tateyama M, Kass RS. Motoike HK, et al. Among authors: tateyama m. J Gen Physiol. 2004 Feb;123(2):155-65. doi: 10.1085/jgp.200308929. J Gen Physiol. 2004. PMID: 14744988 Free PMC article.

6

Calmodulin mediates Ca2+ sensitivity of sodium channels.

Kim J, Ghosh S, Liu H, Tateyama M, Kass RS, Pitt GS. Kim J, et al. Among authors: tateyama m. J Biol Chem. 2004 Oct 22;279(43):45004-12. doi: 10.1074/jbc.M407286200. Epub 2004 Aug 16. J Biol Chem. 2004. PMID: 15316014 Free article.

7

Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome.

Clancy CE, Tateyama M, Kass RS. Clancy CE, et al. Among authors: tateyama m. J Clin Invest. 2002 Nov;110(9):1251-62. doi: 10.1172/JCI15928. J Clin Invest. 2002. PMID: 12417563 Free PMC article.

8

A novel SCN5A mutation associated with long QT-3: altered inactivation kinetics and channel dysfunction.

Rivolta I, Clancy CE, Tateyama M, Liu H, Priori SG, Kass RS. Rivolta I, et al. Among authors: tateyama m. Physiol Genomics. 2002 Sep 3;10(3):191-7. doi: 10.1152/physiolgenomics.00039.2002. Physiol Genomics. 2002. PMID: 12209021

9

K+ channel structure-activity relationships and mechanisms of drug-induced QT prolongation.

Clancy CE, Kurokawa J, Tateyama M, Wehrens XH, Kass RS. Clancy CE, et al. Among authors: tateyama m. Annu Rev Pharmacol Toxicol. 2003;43:441-61. doi: 10.1146/annurev.pharmtox.43.100901.140245. Epub 2002 Jan 10. Annu Rev Pharmacol Toxicol. 2003. PMID: 12540747 Review.

10

Non-equilibrium gating in cardiac Na+ channels: an original mechanism of arrhythmia.

Clancy CE, Tateyama M, Liu H, Wehrens XH, Kass RS. Clancy CE, et al. Among authors: tateyama m. Circulation. 2003 May 6;107(17):2233-7. doi: 10.1161/01.CIR.0000069273.51375.BD. Epub 2003 Apr 14. Circulation. 2003. PMID: 12695286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

408 results

Search Page

Filters